Cidara Therapeutics, Inc.Cidara Therapeutics, Inc.Cidara Therapeutics, Inc.

Cidara Therapeutics, Inc.

No trades
See on Supercharts

CDTX fundamentals

Key facts

Market capitalization
Founded
CEO
Website
About

Cidara Therapeutics, Inc. is a biotechnology company, which engages in the discovery, development, and commercialization of therapeutics for patients facing serious diseases, specifically oncology and infectious diseases. Its product pipeline includes Rezafungin Acetate and Cloudbreak. The company was founded by Kevin M. Forrest, Kevin J. Judice, and H. Shaw Warren in December 2012 and is headquartered in San Diego, CA.

Valuation

Fundamental metrics to determine fair value of the stock

Summary
No data available
There's currently no market capitalization, revenue or net income data to show.
Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

No dividends
CDTX has never paid dividends and has no current plans to do so.

Financial health

Financial position and solvency of the company